Humana, Walmart offer Medicare Part D prescription drug plan
LOUISVILLE, Ky. — Humana will offer Medicare Part D beneficiaries a prescription drug plan co-branded with Wal-Mart Stores, the two companies said Monday.
The plan, originally launched in 2010, will be launched again for 2012 and will include savings on monthly plan premiums, prescription drug copayments and cost-shares for beneficiaries.
The Humana Walmart-Preferred Rx Plan offers a monthly plan premium of $15.10, which the Centers for Medicare and Medicaid Services estimated will be the lowest plan premium in 2012 for a stand-alone Medicare Part D plan in the country. Copayments for some generic drugs will be $1 after deductibles, compared with $2 this year, and copayments will be free for prescriptions filled via Humana’s RightSourceRx mail-order prescription service.
The companies said the plan would offer Medicare Part D beneficiaries cost savings and convenience from the preferred pharmacy network of more than 4,000 Walmart, Sam’s Club, Walmart Neighborhood Market and Walmart Express retail pharmacies.
Les Hamilton joins Hyland’s
LOS ANGELES — Hyland’s on Monday named Les Hamilton as its VP sales. In his new role, Hamilton will be responsible for guiding the company’s sales organization and developing and implementing sales strategy.
“I have known Les for many years and I am confident that he brings to Hyland’s the right mix of experience, accomplishment and culture that aligns perfectly with our core values,” Hyland’s president Dale Nepsa said. “Les will be working closely with our outstanding sales teams in both natural foods and food, drug and mass merchandisers. He will be a valued member of our senior management team, providing a comprehensive sales perspective to the operations of our company.”
Hamilton joins Hyland’s from The Emerson Group, where he served as field sales manager. While with The Emerson Group, Hamilton managed accounts of all sizes, most recently managing the Target business for all of Emerson’s over-the-counter products. Hamilton’s prior experience includes almost 10 years at Target, where he held different positions, including category manager for numerous pharmacy categories and all OTC private-label items.
Hamilton graduated from Indiana University with a Bachelor of Science degree in both marketing and management.
Bristol-Myers Squibb to present at The Liver Meeting
PRINCETON, N.J. — Bristol-Myers Squibb will present 22 study abstracts next month at the 62nd annual meeting of the American Association for the Study of Liver Diseases in San Francisco, the company said.
Key presentations set to take place at the meeting, called The Liver Meeting, include studies on the hepatitis B drug Baraclude (entecavir) and drugs under development for hepatitis C and liver cancer.
"Bristol-Myers Squibb is at the forefront of innovation in researching the treatment of liver diseases," Bristol-Myers Squibb SVP global development and medical affairs for research and development Brian Daniels said. "In hepatitis C, where there remains considerable unmet medical needs, our goal is to increase treatment options for patients by developing a portfolio of compounds with different mechanisms of action."